Literature DB >> 11847733

Pancreatic enzyme therapy and nutritional status of outpatients with chronic pancreatitis.

P A Trolli1, D L Conwell, G Zuccaro.   

Abstract

Patients with chronic pancreatitis are at risk for poor nutritional status. The two major clinical features of chronic pancreatitis are abdominal pain and maldigestion, both resulting in malnutrition. Abdominal pain often results in decreased oral intake, and decreased enzyme production results in maldigestion. Enzyme therapy often is included in treating chronic pancreatitis. There is limited data on the nutritional assessment of outpatients with chronic pancreatitis, and the efficacy of the use of enzyme therapy remains controversial. Serum albumin level and measurement of ideal body weight are two simple measures of nutritional status that can be obtained by gastroenterology nurses. A retrospective chart review was done of patients seen in our outpatient clinic for management of chronic pancreatitis. Serum albumin levels, an indicator of protein calorie malnutrition, were reviewed for 34 patients. Thirty-three percent of these patients were found to have mild-to-moderate protein calorie malnutrition as evidenced by low serum albumin levels. Enzyme therapy information was reviewed for 33 patients. Patients receiving enzyme therapy had better nutritional status based on both serum albumin levels and percent of ideal body weight. Gastroenterology nurses can be instrumental in the recognition and treatment of nutritional deficiencies in chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11847733     DOI: 10.1097/00001610-200103000-00009

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  5 in total

1.  Nutritional Considerations in Pediatric Pancreatitis: A Position Paper from the NASPGHAN Pancreas Committee and ESPGHAN Cystic Fibrosis/Pancreas Working Group.

Authors:  Maisam Abu-El-Haija; Aliye Uc; Steven L Werlin; Alvin Jay Freeman; Miglena Georgieva; Danijela Jojkić-Pavkov; Daina Kalnins; Brigitte Kochavi; Bart G P Koot; Stephanie Van Biervliet; Jaroslaw Walkowiak; Michael Wilschanski; Veronique D Morinville
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-07       Impact factor: 2.839

2.  Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients.

Authors:  Julia B Greer; Phil Greer; Bimaljit S Sandhu; Samer Alkaade; C Mel Wilcox; Michelle A Anderson; Stuart Sherman; Timothy B Gardner; Michele D Lewis; Nalini M Guda; Thiruvengadam Muniraj; Darwin Conwell; Gregory A Cote; Christopher E Forsmark; Peter A Banks; Gong Tang; Kim Stello; Andres Gelrud; Randall E Brand; Adam Slivka; David C Whitcomb; Dhiraj Yadav
Journal:  Nutr Clin Pract       Date:  2018-08-13       Impact factor: 3.080

3.  Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines-A cross-sectional observational study.

Authors:  Friedemann Erchinger; Erling Tjora; Ingrid Kvåle Nordaas; Georg Dimcevski; Søren Schou Olesen; Nanna Jensen; Eva Efsen Dahl; Anders Borch; Camilla Nøjgaard; Srdan Novovic; Giedrus Barauskas; Povilas Ignatavicius; Miroslav Vujasinovic; Matthias Lőhr; Johanna Laukkarinen; Mikael Parhiala; Asbjørn Mohr Drewes; Trond Engjom
Journal:  United European Gastroenterol J       Date:  2022-08-18       Impact factor: 6.866

4.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

5.  Total cholesterol level for assessing pancreatic insufficiency due to chronic pancreatitis.

Authors:  Kenji Hirano; Tomotaka Saito; Suguru Mizuno; Minoru Tada; Naoki Sasahira; Hiroyuki Isayama; Miho Matsukawa; Gyotane Umefune; Dai Akiyama; Kei Saito; Shuhei Kawahata; Naminatsu Takahara; Rie Uchino; Tsuyoshi Hamada; Koji Miyabayashi; Dai Mohri; Takashi Sasaki; Hirofumi Kogure; Natsuyo Yamamoto; Yosuke Nakai; Kazuhiko Koike
Journal:  Gut Liver       Date:  2014-04-23       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.